Shashi Bellam to Treatment Outcome
This is a "connection" page, showing publications Shashi Bellam has written about Treatment Outcome.
Connection Strength
0.023
-
Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome. Crit Care Med. 2022 12 01; 50(12):1701-1713.
Score: 0.023
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.